Effect of clindamycin on Factor-VII activity in healthy cats
1989
Four healthy cats were given clindamycin orally in daily doses of 25 or 50 mg/kg of body weight for 6 weeks. Significant change in Factor-VII activity was not found, compared with pretreatment values. In 2 cats tested, toxin produced by Clostridium difficile was not detected in fecal samples obtained before treatment and at 6 weeks after treatment, suggesting that intestinal overgrowth by C difficile did not develop. Results of the study seemed to indicate that orally administered clindamycin does not measurably reduce synthesis of vitamin K-dependent clotting factors in healthy cats.
显示更多 [+] 显示较少 [-]AGROVOC关键词
书目信息
American journal of veterinary research
卷
50
期
3
页码
393
- 395
ISSN
0002-9645
出版者
American Chemical Society
其它主题
Female; Adverse effects; Male; Veterinary; Chemically induced; Factor vii; Cat diseases; Drug effects
语言
英语
注释
2019-12-05
类型
Text; Journal Article
2024-02-28
MODS